Platform|API|Archive|Contact
Humanexa SignalsPharmaceutical Intelligence
Subscribe
Signals
Regulatory
  • FDA
  • EMA
  • MHRA
  • PMDA
  • Health Canada
Clinical
  • Phase I
  • Phase II
  • Phase III
  • Readouts
  • Enrollment Signals
Competitive
  • Pipeline Tracking
  • Company Moves
  • Asset Intelligence
  • Landscape Reports
Markets
  • Pricing
  • Access
  • Commercial
  • Launch Tracking
M&A Watch
  • Licensing
  • Acquisitions
  • Partnerships
  • Capital Raises
StrategyCatalystsPricing
Humanexa Signals

Data-driven pharmaceutical intelligence for biotech investors, pharma operators, consultants, and intelligence teams.

Powered by Humanexa

Categories

  • Regulatory
  • Clinical
  • Competitive
  • Markets
  • M&A Watch
  • Strategy
  • Catalyst Tracker

Company

  • Pricing
  • Partner with us
  • Subscribe
  • Contact
  • Privacy

Subscribe to Humanexa Signals

Weekly intelligence for pharma decision-makers.

No paywall. No spam. Unsubscribe anytime.

© 2026 Humanexa Signals. All rights reserved.

Intelligence powered by the Humanexa engine.

Therapeutic Area

Infectious Diseases

Therapeutic area intelligence for Infectious Diseases with 5 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals
5
Catalysts
0
Companies
1

Companies

Roche →

Assets

Hepatitis →
Tuberculosis Detection →

Recent signals(5)

ClinicalJuly 29, 2026

Study on Liver Transplantation in HCV-HIV Coinfected Patients Launched

A clinical trial has been initiated to assess the feasibility of liver transplantation in patients with HCV and HIV coinfection, focusing on survival rates and drug interactions.

RegulatoryJuly 15, 2026

Roche's Elecsys IGRA TB Test Receives CE Mark for Tuberculosis Detection

Roche's Elecsys IGRA TB test has received CE Mark approval, enabling rapid and efficient tuberculosis infection testing.

StrategyJuly 14, 2026

Roche launches first fully automated cobas HDV test for Hepatitis D diagnosis

Roche has introduced the cobas HDV test, the first fully automated diagnostic solution for Hepatitis D Virus.

CompetitiveJuly 14, 2026

Roche Launches First Fully Automated HDV Test to Enhance Diagnosis and Monitoring

Roche has introduced the cobas HDV test, the first fully automated diagnostic solution for Hepatitis D Virus, enhancing diagnosis and treatment monitoring.

RegulatoryJuly 9, 2026

Roche's Elecsys IGRA TB Test Receives CE Mark for Tuberculosis Detection

Roche's Elecsys IGRA TB test has received CE Mark approval, enabling rapid and automated tuberculosis infection testing.

Upcoming catalysts

No catalysts indexed for this entity yet.

Indications

Hepatitis C →
Hepatitis D →
Infectious Diseases →

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.